Cancer Biomarkers: Easier Said Than Done (Cancer Diagnostics: Overview)
Clinical Chemistry 2002, August, 48, 8
-
- CHF 3.00
-
- CHF 3.00
Publisher Description
Cancer biomarkers are firmly embedded clinically as essential diagnostic modalities to assess cancer. Human chorionic gonadotropin and a-fetoprotein for germ cell tumors, monoclonal serum and urine electrophoretic peaks for myeloma, and prostate-specific antigen for prostate cancer represent only a few of the successful cancer biomarkers now used clinically. The explosion of research activity in cancer biomarkers over the past decade can be ascribed to the convergence of science, technology, and regulatory and social factors as follows:
GENRE
Science & Nature
RELEASED
2002
1 August
LANGUAGE
EN
English
LENGTH
12
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SIZE
170.3
KB
More Books by Clinical Chemistry
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments (Special Report) (Polymerase Chain Reaction) (Report)
2009
D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report)
2004
Congenital Analbuminemia Attributable to Compound Heterozygosity for Novel Mutations in the Albumin Gene (Technical Briefs)
2005
Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs)
2005
Measurement of Pro-C-Type Natriuretic Peptide in Plasma (Technical Briefs)
2005
Newborn Screening for Lysosomal Storage Disorders (Editorials)
2005